KATHMANDU, Jan. 31: Kathmandu, the capital city of Nepal, has not even been safe, thanks to the increasing risks of filaria.
The capital city, however, is not at high risk of filaria but considered to be one of the risky areas in the country, according to Public Health Service Office, Kathmandu.
Around 1,750,000 population in the Kathmandu district is at risk of filaria and the Office has been making preparations to administer anti-filaria medicines to some 1,550,000 people this year.
According to the information disseminated by the Office by organizing a press conference here today, the office would mobilize some 400 health workers to administer Albendazol and Diethyl Carbamazine for three days beginning on February 4-7 to eradicate the disease in the city, said Public Health Officer, Shreekrishna Bhatta.
The symptoms of the disease that is transferred from flies, especially the mosquito, are fever in cold season, blue and black marks would appear in hands and legs, and leg pain, among others. The disease can be cured if it is treated at the initial stage.
He urged all the people above two years of age to take the medicine, saying that if the medicine is taken for five years, there would be no risk of filaria.
During the campaign organized last year, only 48 per cent of people had taken the medicines.